Blood Transplantation for Patients With Hematologic Malignancies or Bone Marrow Failure States
Stopped early · Not applicable
Conditions studied: Leukemia, Non Hodgkin's Lymphoma, Aplastic Anemia
In brief
The purpose of this study is to assess early treatment failure within 100 days and to assess the effect of this regimen on engraftment, GVHD, immune recovery, relapse of malignancy and survival.
Key facts
- Study ID
- NCT00038779
- Run by
- M.D. Anderson Cancer Center
- People needed
- 7
- Starts
- 1996-08-14
- Expected to finish
- 2004-09-20
- Last updated by the study team
- 2018-10-30
Who can join
Age: any, up to 49. Sex: any. Healthy volunteers: not accepted.
Where it is running
- MD Anderson Cancer Center — Houston, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.